Us Snf Based Dialysis Market Report: Market Size & Forecast 2026

SNF-based dialysis encompasses hemodialysis and peritoneal dialysis services administered at skilled nursing facilities that are certified to provide sub-acute and long-term care to medically complex patients, including those with renal failure. This market segment occupies a critical position in the U.S. renal care continuum, serving patients who are often elderly, frail, or have multiple comorbidities that make frequent travel to standalone dialysis centers impractical. Revenue flows primarily through Medicare and Medicaid fee-for-service and managed care contracts, with CMS reimbursement structures playing a central role in shaping facility economics and patient access.

• •The market is valued at approximately $31.07 billion in 2025 and is expected to reach over $40 billion by the early 2030s at a 3.97% CAGR
• •Medicare and Medicaid cover the majority of SNF-based dialysis patients under ESRD programs bundled into broader SNF per-diem rates
• •Over 600,000 Americans live with end-stage renal disease, with a growing share managed in SNF settings due to aging demographics and care complexity

The principal growth engine is the aging U.S. population, as adults 65 and older represent the fastest-growing demographic cohort and are disproportionately affected by chronic kidney disease and ESRD. Favorable regulatory and reimbursement developments, including CMS policy adjustments that recognize the cost-effectiveness of dialysis delivered in SNF settings, have improved the financial viability of these services for operators. Additional momentum comes from rising prevalence of diabetes and hypertension, the leading upstream causes of ESRD, as well as clinical evidence demonstrating that well-managed SNF-based dialysis can reduce hospitalization rates and overall healthcare spending.

• •The U.S. population aged 65 and older is projected to reach 95 million by 2030, directly expanding the ESRD patient pool eligible for SNF-based care
• •CMS bundled payment reforms and SNF value-based purchasing programs incentivize facilities to reduce avoidable hospital readmissions, supporting investment in on-site dialysis capabilities
• •Rising prevalence of CKD stages 3-5, driven by obesity and diabetes epidemics, creates a growing upstream pipeline of patients transitioning to ESRD and SNF-based therapy

Geographically, the market is concentrated in states with large elderly populations and dense networks of SNFs, including California, Texas, Florida, New York, and Pennsylvania, which together account for a substantial share of SNF-based dialysis encounters. Urban and suburban markets tend to have higher penetration due to greater facility density and nephrology workforce availability, while rural areas face access challenges that are beginning to be addressed through telehealth-enabled dialysis programs and mobile dialysis units. Within the service mix, in-center hemodialysis delivered within SNFs remains the dominant modality, though peritoneal dialysis adoption at SNFs is gradually increasing as training and support infrastructure improves.

• •The South and West regions are expected to see the fastest growth due to above-average rates of CKD and ESRD and expanding SNF construction activity
• •In-center hemodialysis represents the majority of SNF-based dialysis volume, while peritoneal dialysis is gaining share through CMS home dialysis incentives
• •Rural SNF dialysis access gaps are being partially addressed by telehealth integration and portable dialysis technology, though disparities persist

What are the recent trends and outlook?

Value-based care models are reshaping the SNF-based dialysis landscape, with CMS initiatives such as the ESRD Treatment Choices Model and SNF Quality Reporting Program pushing providers to prioritize patient outcomes, care coordination, and reduced hospital utilization over volume. Digital health technologies, including remote patient monitoring, electronic health record interoperability, and AI-assisted staffing optimization, are being adopted to improve clinical quality and operational efficiency within SNF dialysis units. Looking ahead, the market is expected to consolidate as larger renal care companies deepen SNF partnerships and smaller independent operators seek scale, while ongoing CMS policy reviews of bundled ESRD payment rates remain the most significant near-term regulatory variable.

• •The ESRD Treatment Choices Model (ETC) and value-based purchasing programs are accelerating the shift toward home and SNF-based modalities by offering financial incentives to reduce in-center dialysis reliance
• •Remote monitoring and interoperable EHR systems are improving care coordination between SNFs, dialysis providers, and nephrologists, supporting better patient outcomes and lower readmission rates
• •CMS reimbursement policy updates, including potential revisions to bundled ESRD payments, represent the most critical external factor that could accelerate or constrain market growth in the 2026-2030 period